Skip to content
Angle logo
  • About us
    • Discover ANGLE
    • Our team
    • Careers
    • Events
    • News
    • Corporate social responsibility
  • Technology
    • Parsortix® technology
    • Parsortix PC1 system – clinical
    • Parsortix PR1 system – research
  • Product solutions
    • Discover all Product solutions
    • Systems:
      • Parsortix PC1 system – clinical
      • Parsortix PR1 system – research
    • Downstream analysis:
      • Portrait+ CTC Staining Kit
  • Laboratory services
    • Discover all Laboratory services
    • Immunofluorescence:
      • Enumeration
      • Portrait®Flex
      • DNA damage response (DDR)
      • Portrait®PD-L1
      • Custom CTC assays
      • HER2
  • Resources
    • View all resources
      • Publications
      • Posters
      • Articles
      • Whitepapers
      • Presentations
    • Translational research
      • Breast cancer
      • Prostate cancer
      • Ovarian cancer
    • Instructions for Use documents
    • Product information
  • Contact us
  • Investors
Investors
  • Business strategy
  • Market size
  • Regulatory news
  • Share price
  • Financial reports
  • Financial Calendar
  • Corporate responsibility report
  • Glossary
  • Email alerts
AIM Rule 26
  • Corporate governance
  • Significant shareholders
  • ADR
  • Advisors
Corporate presentations
  • ANGLE in the media
  • Analyst research

Latest report

Annual Report December 2023

Please click the links below to download our Annual and Interim Reports and Financial Statements

Open PDF

For any investor relations queries please contact

investor@angleplc.com
  • About Us
    • Discover ANGLE
    • Our team
    • Careers
    • Events
    • Corporate social responsibility
  • Technology
    • Parsortix®technology
    • Parsortix PC1 system – clinical
    • Parsortix PR1 system – research
  • Product solutions
    • Discover all Product solutions
    • Systems:
      • Portrait+ CTC staining kit
    • Downstream analysis:
      • Parsortix PC1 system – clinical
      • Parsortix PR1 system – research
  • Laboratory services
    • Discover all Laboratory services
    • Immunofluorescence:
      • CTC enumeration
      • Portrait®Flex
      • DNA damage response (DDR)
      • Portrait®PD-L1
      • Custom CTC assays
      • HER2
  • Resources
    • Discover all Resources
    • Publications
    • Translational research
    • Instructions for Use documents
    • Product information
  • Contact us
  • Investors
    • Investors
      • Business strategy
      • Market size
      • Regulatory news
      • Share price
      • Financial reports
      • Corporate responsibility report
      • Glossary
      • Email alerts
    • AIM 26
      • Corporate governance
      • Significant shareholders
      • ADR
      • Advisors
    • Corporate presentations
      • ANGLE in the media
      • Analyst research

For any investor relations queries please contact

investor@angleplc.com

Come see us at the 7th Annual DDR Inhibitors Summit

Posted on January 30, 2024June 5, 2024 by Sangeetha Dhandapani

From Jan 30-Feb 1 at The Colonnade in Boston!

  • Column 1
    • About us
      • Our team
      • Careers
      • Events
      • News
      • Corporate social responsibility
    • Technology
      • Parsortix®technology
      • Parsortix PC1 system – clinical
      • Parsortix PR1 system – research
  • Column 2
    • Product solutions
      • Parsortix PC1 system – clinical
      • Parsortix PR1 system – research
      • Portrait+ CTC staining kit
    • Laboratory services
      • CTC enumeration
      • Portrait®Flex
      • DNA damage response (DDR)
      • Portrait®PD-L1
      • Custom CTC assays
      • HER2
  • Column 3
    • Resources
      • Translational research
      • Product information
      • Publications
      • Instructions for Use documents
  • Column 4
    • Investors
      • Business strategy
      • Market size
      • Regulatory news
      • Share price
      • Corporate presentations
      • Financial reports
      • Corporate responsibility report
      • AIM Rule 26
      • Email alerts
      • Corporate governance
      • ANGLE in the media
  • Column 5
    • Contact us
    • Legal & compliance
      • ISO certificates
  • Column 1
    • About us
      • Our team
      • Careers
      • Events
      • News
      • Corporate social responsibility
    • Technology
      • Parsortix®technology
      • Parsortix PC1 system – clinical
      • Parsortix PR1 system – research
  • Column 2
    • Product solutions
      • Parsortix PC1 system – clinical
      • Parsortix PR1 system – research
      • Portrait+ CTC staining kit
    • Laboratory services
      • CTC enumeration
      • Portrait®Flex
      • DNA damage response (DDR)
      • Portrait®PD-L1
      • Custom CTC assays
      • HER2
  • Column 3
    • Resources
      • Translational research
      • Product information
      • Publications
      • Instructions for Use documents
  • Column 4
    • Investors
      • Business strategy
      • Market size
      • Regulatory news
      • Share price
      • Corporate presentations
      • Financial reports
      • Corporate responsibility report
      • AIM Rule 26
      • Email alerts
      • Corporate governance
      • ANGLE in the media
  • Column 5
    • Contact us
    • Legal & compliance
      • ISO certificates
2 Occam Court, Occam Road, Surrey Research Park, Guildford, GU2 7QB, UK +44 (0)1483 343434
5100 Campus Drive, Suite 120, Plymouth Meeting, PA 19462, USA +1 610 233 4712
10 Nugent Road, Surrey Research Park, Guildford, GU2 7AF, UK
© ANGLE plc 2024
  • Privacy policy
  • Cookies declaration
  • Terms & conditions